General Research identifies common neuroimmune signatures in rapid-acting antidepressantsBy Healthcare Propulsion StaffJuly 30, 20260 In a new study, researchers from The University of Texas MD Anderson Cancer Center have uncovered insights that may help explain how rapid-acting antidepressants, such as ketamine…
